Visual Evoked Potential Findings in Endometriosis Patients Treated with Dienogest
Journal of Ophthalmic and Optometric Sciences · 23.09.2023
DOI: 10.22037/joos.v7i4.47020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ophthalmic and Optometric Sciences, erschienen am 23.09.2023. Verfasst von Mohammad Eslami Vaghar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
The aim of the present study was to investigate possible toxic effects of Dienogest treatment on visual pathway among endometriosis patients using visual evoked potential (VEP) measurements. Patients and Methods: A total of 26 eyes from 13 females aged between 25 and 42 years who received Dienogest for the treatment of endometriosis were included as the case group. VEP measurements were taken from the case group and compared with results from 26 eyes of 13 healthy females with no history of Dienogest use, who served as the control group.
Results
There were no significant differences between the case and control groups in terms of the latency and amplitude of the VEP P100 peak.
Conclusion
Dienogest does not affect the visual pathway in patients, as demonstrated by visual evoked potential measurements.
Schlagwörter
Zitieren
APA
Vaghar, M. E., & Shushtarian, S. M. M. (2023). Visual Evoked Potential Findings in Endometriosis Patients Treated with Dienogest. Journal of Ophthalmic and Optometric Sciences. https://doi.org/10.22037/joos.v7i4.47020
Vancouver
Vaghar ME, Shushtarian SMM. Visual Evoked Potential Findings in Endometriosis Patients Treated with Dienogest. Journal of Ophthalmic and Optometric Sciences. 2023. doi:10.22037/joos.v7i4.47020
BibTeX
@article{Vaghar2023,
author = {Vaghar, Mohammad Eslami and Shushtarian, Seyed Mohammad Masoud},
title = {Visual Evoked Potential Findings in Endometriosis Patients Treated with Dienogest},
journal = {Journal of Ophthalmic and Optometric Sciences},
year = {2023},
doi = {10.22037/joos.v7i4.47020}
}
EUVIMED